miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)

被引:2
|
作者
Mu, Hongxiang [1 ]
Zhang, Wenmao [1 ]
Qiu, Ye [1 ]
Tao, Ting [1 ]
Wu, Hongliang [1 ]
Chen, Zhuo [1 ]
Xu, Gaosheng [1 ]
机构
[1] Yueyang Maternal & Child Hlth Hosp, 693 Baling Rd, Yueyang 414000, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
breast cancer; microRNA; biomarker; signaling pathway; treatment and prognosis; KAPPA-B; PATHWAY; PROLIFERATION; CELLS;
D O I
10.3892/ijo.2021.5196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is one of the most common malignancies affecting women. BC is a heterogeneous disease that involves multiple oncogenic pathways and/or genetic alterations. MicroRNAs (miRNAs or miRs) are a type of small endogenous single-stranded RNA that pairs with the 3 ' untranslated region of target mRNAs to negatively regulate the gene expression of specific mRNA targets. miRNAs are thus involved in various cellular processes, including proliferation, differentiation, apoptosis, migration, metabolism and the stress response. Over the past decade, a number of studies have demonstrated that the expression levels of miRNAs are dysregulated in a number of types of cancer, including BC. In the present review, recent research on miRNAs involved in the occurrence and development of BC, as well as the current findings on miRNAs as potential biomarkers for BC are summarized. In addition, the association between miRNA dysregulation and BC development, and the current status of BC treatment and prognosis are discussed. Finally, several signaling pathways involved in the development of BC and the potential roles of miRNAs in these pathways are reviewed. The present review aims to provide insight into the roles of miRNAs in BC.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers
    Malla, Rama Rao
    Pandrangi, Santhi
    Kumari, Seema
    Gavara, Murali Mohan
    Badana, Anil Kumar
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (06) : 383 - 391
  • [32] Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy: A Narrative Review
    Shalannandia, Widad Aghnia
    Chou, Yoan
    Bashari, Muhammad Hasan
    Khairani, Astrid Feinisa
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 689 - 704
  • [33] Secretoglobins: Potential markers for breast cancer
    Duffy, M. J.
    Culleton, J.
    Flanagan, L.
    O'Brien, N.
    TUMOR BIOLOGY, 2006, 27 : 27 - 27
  • [34] A review of the biological role of miRNAs in prostate cancer suppression and progression
    Doghish, Ahmed S.
    Ismail, Ahmed
    El-Mahdy, Hesham A.
    Elkady, Mohamed A.
    Elrebehy, Mahmoud A.
    Sallam, Al-Aliaa M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 197 : 141 - 156
  • [35] Tumorigenesis and Stage Progression in Rectal Cancer is Paralleled by Progressive Differential Expression in a Subset of Genes and miRNAs
    Chow, O. S.
    Pelossof, R.
    Smith, J.
    Fairchild, L.
    Chen, C.
    Chen, Z.
    Leslie, C. S.
    Aguilar, J. Garcia
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S86 - S86
  • [36] Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer
    Huan Chen
    Guoping Xie
    Qunying Luo
    Yisha Yang
    Siheng Hu
    Functional & Integrative Genomics, 2023, 23
  • [37] The role of miRNAs in cyclooxygenase-2-mediated breast cancer progression
    Dunn, Leanna
    Majumder, Mousumi
    Lala, Peeyush
    CANCER RESEARCH, 2012, 72
  • [38] Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer
    Chen, Huan
    Xie, Guoping
    Luo, Qunying
    Yang, Yisha
    Hu, Siheng
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (03)
  • [39] The Virology of Breast Cancer: Viruses as the Potential Causative Agents of Breast Tumorigenesis
    Lehrer, Steven
    Rheinstein, Peter H.
    DISCOVERY MEDICINE, 2019, 27 (148) : 163 - 166
  • [40] Aberrant Expression, and Potency as Cancer Markers/Targets, of Splicing Regulators in Breast Cancer
    Lacroix-Triki, M.
    Dupuy, J. F.
    Dalenc, F.
    Dejean, S.
    Besse, P.
    Roche, H.
    Rochaix, P.
    Vagner, S.
    LABORATORY INVESTIGATION, 2009, 89 : 53A - 53A